Provided by Tiger Fintech (Singapore) Pte. Ltd.

BRONCUS-B

3.080
+0.2408.45%
Volume:5.28M
Turnover:15.58M
Market Cap:1.62B
PE:-12.54
High:3.120
Open:2.890
Low:2.810
Close:2.840
52wk High:3.280
52wk Low:0.460
Shares:527.00M
HK Float Shares:527.00M
Volume Ratio:0.96
T/O Rate:1.00%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.246
ROE:-8.63%
ROA:-7.56%
PB:1.22
PE(LYR):-12.54
PS:25.45

Loading ...

Company Profile

Company Name:
BRONCUS-B
Exchange:
SEHK
Establishment Date:
2012
Employees:
200
Office Location:
Building 8,Room 801, 8/F,No. 88 Jiangling Road, Xixing Street,Binjiang District,Hangzhou,Zhejiang Province,China
Zip Code:
- -
Fax:
86 571 8796 9085
Introduction:
Broncus Holding Corp is an investment holding company providing innovative solutions for lung diseases. The Company's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solutions and navigation platforms. The diagnostic solutions pruducts include FleXNeedle, ATV Sheath, ATV Balloon and others. The lung cancer treatment solutions products include InterVapor for lung cancer, H-Marker and others. The chronic obstructive pulmonary disease (COPD) solutions products include InterVapor for COPD and TLD Ablation System. The navigation platform products include Lungpoint, Lungpro, New Generation Navigation Platform and others.

Directors

Name
Position
XU Hong
Chairman of the Board,Executive Director
GAN Bo Wen
Independent Director,Chairman of the Remuneration and Assessment Committee,Chairman of the Nomination Committee,Audit Committee Chairman
HUANG Yi Qian
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
David Scott Lim
Independent Director
ZHANG Ao
Director
KUANG Yan Hong
Director

Shareholders

Name
Position
XU Hong
CEO,General Manager,CTO
SUN Jia En
Corporate Secretary